Key result
Subvalvular catheter ablation of the cavotricuspid isthmus was described as a challenging procedure for atrial tachycardia in a patient with Ebstein's anomaly and a bioprosthetic tricuspid valve.
Case Report (n=1)
Highlights the technical challenges and feasibility of subvalvular catheter ablation of the cavotricuspid isthmus in a patient with Ebstein's anomaly and prior tricuspid valve replacement.
Answers are grounded in this paper and cite their sources.
May complicate CTI ablation after TVR in EA; leaves open optimal strategies for this population.
Ebstein's anomaly (EA) is a congenital malformation of the tricuspid valve that often requires tricuspid valve replacement (TVR). EA patients have a high burden of atrial tachycardia owing to a combination of prior surgical incisions and abnormal atrial hemodynamics. Catheter ablation for atrial tachycardia, especially when the cavotricuspid isthmus (CTI) is a critical component of the circuit, may be quite challenging due to positioning of the bioprosthetic valve over various portions of this isthmus.
No takes yet. Share an insight, caveat, or question.
Gallotti et al. (2017) conducted a case report in Ebstein's anomaly and tricuspid valve replacement with atrial tachycardia (n=1). Subvalvular catheter ablation of the cavotricuspid isthmus was evaluated. Subvalvular catheter ablation of the cavotricuspid isthmus was described as a challenging procedure for atrial tachycardia in a patient with Ebstein's anomaly and a bioprosthetic tricuspid valve.
Synapse has enriched 10 related papers. Consider them for comparative context: